Selected research
Market Analysis & Forecast
Global Kinase Panel Screening and Profiling Market Analysis and Forecast 2026-2032
Market perspective
The global Kinase Panel Screening and Profiling market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Kinase Panel Screening and Profiling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Kinase Panel Screening and Profiling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Kinase Panel Screening and Profiling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Kinase Panel Screening and Profiling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Kinase Panel Screening and Profiling include MedChemExpress, Eurofins DiscoverX, Thermo Fisher Scientific, Reaction Biology, BPS Bioscience, Creative Biogene, Luceome Biotechnologies, Kinexus and LC Sciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Kinase Panel Screening and Profiling, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Kinase Panel Screening and Profiling, also provides the revenue of main regions and countries. Of the upcoming market potential for Kinase Panel Screening and Profiling, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Kinase Panel Screening and Profiling revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Kinase Panel Screening and Profiling market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Kinase Panel Screening and Profiling revenue, projected growth trends, production technology, application and end-user industry.
Kinase Panel Screening and Profiling Segment by Company
MedChemExpress
Eurofins DiscoverX
Thermo Fisher Scientific
Reaction Biology
BPS Bioscience
Creative Biogene
Luceome Biotechnologies
Kinexus
LC Sciences
HD Biosciences
Caliper Life Sciences
Profacgen
Kinase Panel Screening and Profiling Segment by Type
Radioisotope Method
Homogeneous Non-radioisotope Method
Kinase Panel Screening and Profiling Segment by Application
Enterprise
Research Institute
Kinase Panel Screening and Profiling Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kinase Panel Screening and Profiling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Kinase Panel Screening and Profiling and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kinase Panel Screening and Profiling.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Kinase Panel Screening and Profiling in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Kinase Panel Screening and Profiling company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Kinase Panel Screening and Profiling revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Radioisotope Method
- Homogeneous Non-radioisotope Method
Applications
- Enterprise
- Research Institute
Companies covered
- MedChemExpress
- Eurofins DiscoverX
- Thermo Fisher Scientific
- Reaction Biology
- BPS Bioscience
- Creative Biogene
- Luceome Biotechnologies
- Kinexus
- LC Sciences
- HD Biosciences
- Caliper Life Sciences
- Profacgen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Kinase Panel Screening and Profiling Market by Type
- 1.2.1 Global Kinase Panel Screening and Profiling Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Radioisotope Method
- 1.2.3 Homogeneous Non-radioisotope Method
- 1.3 Kinase Panel Screening and Profiling Market by Application
- 1.3.1 Global Kinase Panel Screening and Profiling Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Enterprise
- 1.3.3 Research Institute
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Kinase Panel Screening and Profiling Market Dynamics
- 2.1 Kinase Panel Screening and Profiling Industry Trends
- 2.2 Kinase Panel Screening and Profiling Industry Drivers
- 2.3 Kinase Panel Screening and Profiling Industry Opportunities and Challenges
- 2.4 Kinase Panel Screening and Profiling Industry Restraints
3 Global Growth Perspective
- 3.1 Global Kinase Panel Screening and Profiling Market Perspective (2021-2032)
- 3.2 Global Kinase Panel Screening and Profiling Growth Trends by Region
- 3.2.1 Global Kinase Panel Screening and Profiling Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Kinase Panel Screening and Profiling Market Size by Region (2021-2026)
- 3.2.3 Global Kinase Panel Screening and Profiling Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Kinase Panel Screening and Profiling Revenue by Players
- 4.1.1 Global Kinase Panel Screening and Profiling Revenue by Players (2021-2026)
- 4.1.2 Global Kinase Panel Screening and Profiling Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Kinase Panel Screening and Profiling Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Kinase Panel Screening and Profiling Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Kinase Panel Screening and Profiling Key Players Headquarters & Area Served
- 4.4 Global Kinase Panel Screening and Profiling Players, Product Type & Application
- 4.5 Global Kinase Panel Screening and Profiling Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Kinase Panel Screening and Profiling Market CR5 and HHI
- 4.6.3 2025 Kinase Panel Screening and Profiling Tier 1, Tier 2, and Tier 3
5 Kinase Panel Screening and Profiling Market Size by Type
- 5.1 Global Kinase Panel Screening and Profiling Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Kinase Panel Screening and Profiling Revenue by Type (2021-2032)
- 5.3 Global Kinase Panel Screening and Profiling Revenue Market Share by Type (2021-2032)
6 Kinase Panel Screening and Profiling Market Size by Application
- 6.1 Global Kinase Panel Screening and Profiling Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Kinase Panel Screening and Profiling Revenue by Application (2021-2032)
- 6.3 Global Kinase Panel Screening and Profiling Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 MedChemExpress
- 7.1.1 MedChemExpress Company Information
- 7.1.2 MedChemExpress Business Overview
- 7.1.3 MedChemExpress Kinase Panel Screening and Profiling Revenue and Gross Margin (2021-2026)
- 7.1.4 MedChemExpress Kinase Panel Screening and Profiling Product Portfolio
- 7.1.5 MedChemExpress Recent Developments
- 7.2 Eurofins DiscoverX
- 7.2.1 Eurofins DiscoverX Company Information
- 7.2.2 Eurofins DiscoverX Business Overview
- 7.2.3 Eurofins DiscoverX Kinase Panel Screening and Profiling Revenue and Gross Margin (2021-2026)
- 7.2.4 Eurofins DiscoverX Kinase Panel Screening and Profiling Product Portfolio
- 7.2.5 Eurofins DiscoverX Recent Developments
- 7.3 Thermo Fisher Scientific
- 7.3.1 Thermo Fisher Scientific Company Information
- 7.3.2 Thermo Fisher Scientific Business Overview
- 7.3.3 Thermo Fisher Scientific Kinase Panel Screening and Profiling Revenue and Gross Margin (2021-2026)
- 7.3.4 Thermo Fisher Scientific Kinase Panel Screening and Profiling Product Portfolio
- 7.3.5 Thermo Fisher Scientific Recent Developments
- 7.4 Reaction Biology
- 7.4.1 Reaction Biology Company Information
- 7.4.2 Reaction Biology Business Overview
- 7.4.3 Reaction Biology Kinase Panel Screening and Profiling Revenue and Gross Margin (2021-2026)
- 7.4.4 Reaction Biology Kinase Panel Screening and Profiling Product Portfolio
- 7.4.5 Reaction Biology Recent Developments
- 7.5 BPS Bioscience
- 7.5.1 BPS Bioscience Company Information
- 7.5.2 BPS Bioscience Business Overview
- 7.5.3 BPS Bioscience Kinase Panel Screening and Profiling Revenue and Gross Margin (2021-2026)
- 7.5.4 BPS Bioscience Kinase Panel Screening and Profiling Product Portfolio
- 7.5.5 BPS Bioscience Recent Developments
- 7.6 Creative Biogene
- 7.6.1 Creative Biogene Company Information
- 7.6.2 Creative Biogene Business Overview
- 7.6.3 Creative Biogene Kinase Panel Screening and Profiling Revenue and Gross Margin (2021-2026)
- 7.6.4 Creative Biogene Kinase Panel Screening and Profiling Product Portfolio
- 7.6.5 Creative Biogene Recent Developments
- 7.7 Luceome Biotechnologies
- 7.7.1 Luceome Biotechnologies Company Information
- 7.7.2 Luceome Biotechnologies Business Overview
- 7.7.3 Luceome Biotechnologies Kinase Panel Screening and Profiling Revenue and Gross Margin (2021-2026)
- 7.7.4 Luceome Biotechnologies Kinase Panel Screening and Profiling Product Portfolio
- 7.7.5 Luceome Biotechnologies Recent Developments
- 7.8 Kinexus
- 7.8.1 Kinexus Company Information
- 7.8.2 Kinexus Business Overview
- 7.8.3 Kinexus Kinase Panel Screening and Profiling Revenue and Gross Margin (2021-2026)
- 7.8.4 Kinexus Kinase Panel Screening and Profiling Product Portfolio
- 7.8.5 Kinexus Recent Developments
- 7.9 LC Sciences
- 7.9.1 LC Sciences Company Information
- 7.9.2 LC Sciences Business Overview
- 7.9.3 LC Sciences Kinase Panel Screening and Profiling Revenue and Gross Margin (2021-2026)
- 7.9.4 LC Sciences Kinase Panel Screening and Profiling Product Portfolio
- 7.9.5 LC Sciences Recent Developments
- 7.10 HD Biosciences
- 7.10.1 HD Biosciences Company Information
- 7.10.2 HD Biosciences Business Overview
- 7.10.3 HD Biosciences Kinase Panel Screening and Profiling Revenue and Gross Margin (2021-2026)
- 7.10.4 HD Biosciences Kinase Panel Screening and Profiling Product Portfolio
- 7.10.5 HD Biosciences Recent Developments
- 7.11 Caliper Life Sciences
- 7.11.1 Caliper Life Sciences Company Information
- 7.11.2 Caliper Life Sciences Business Overview
- 7.11.3 Caliper Life Sciences Kinase Panel Screening and Profiling Revenue and Gross Margin (2021-2026)
- 7.11.4 Caliper Life Sciences Kinase Panel Screening and Profiling Product Portfolio
- 7.11.5 Caliper Life Sciences Recent Developments
- 7.12 Profacgen
- 7.12.1 Profacgen Company Information
- 7.12.2 Profacgen Business Overview
- 7.12.3 Profacgen Kinase Panel Screening and Profiling Revenue and Gross Margin (2021-2026)
- 7.12.4 Profacgen Kinase Panel Screening and Profiling Product Portfolio
- 7.12.5 Profacgen Recent Developments
8 North America
- 8.1 North America Kinase Panel Screening and Profiling Revenue (2021-2032)
- 8.2 North America Kinase Panel Screening and Profiling Revenue by Type (2021-2032)
- 8.2.1 North America Kinase Panel Screening and Profiling Revenue by Type (2021-2026)
- 8.2.2 North America Kinase Panel Screening and Profiling Revenue by Type (2027-2032)
- 8.3 North America Kinase Panel Screening and Profiling Revenue Share by Type (2021-2032)
- 8.4 North America Kinase Panel Screening and Profiling Revenue by Application (2021-2032)
- 8.4.1 North America Kinase Panel Screening and Profiling Revenue by Application (2021-2026)
- 8.4.2 North America Kinase Panel Screening and Profiling Revenue by Application (2027-2032)
- 8.5 North America Kinase Panel Screening and Profiling Revenue Share by Application (2021-2032)
- 8.6 North America Kinase Panel Screening and Profiling Revenue by Country
- 8.6.1 North America Kinase Panel Screening and Profiling Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Kinase Panel Screening and Profiling Revenue by Country (2021-2026)
- 8.6.3 North America Kinase Panel Screening and Profiling Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Kinase Panel Screening and Profiling Revenue (2021-2032)
- 9.2 Europe Kinase Panel Screening and Profiling Revenue by Type (2021-2032)
- 9.2.1 Europe Kinase Panel Screening and Profiling Revenue by Type (2021-2026)
- 9.2.2 Europe Kinase Panel Screening and Profiling Revenue by Type (2027-2032)
- 9.3 Europe Kinase Panel Screening and Profiling Revenue Share by Type (2021-2032)
- 9.4 Europe Kinase Panel Screening and Profiling Revenue by Application (2021-2032)
- 9.4.1 Europe Kinase Panel Screening and Profiling Revenue by Application (2021-2026)
- 9.4.2 Europe Kinase Panel Screening and Profiling Revenue by Application (2027-2032)
- 9.5 Europe Kinase Panel Screening and Profiling Revenue Share by Application (2021-2032)
- 9.6 Europe Kinase Panel Screening and Profiling Revenue by Country
- 9.6.1 Europe Kinase Panel Screening and Profiling Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Kinase Panel Screening and Profiling Revenue by Country (2021-2026)
- 9.6.3 Europe Kinase Panel Screening and Profiling Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Kinase Panel Screening and Profiling Revenue (2021-2032)
- 10.2 China Kinase Panel Screening and Profiling Revenue by Type (2021-2032)
- 10.2.1 China Kinase Panel Screening and Profiling Revenue by Type (2021-2026)
- 10.2.2 China Kinase Panel Screening and Profiling Revenue by Type (2027-2032)
- 10.3 China Kinase Panel Screening and Profiling Revenue Share by Type (2021-2032)
- 10.4 China Kinase Panel Screening and Profiling Revenue by Application (2021-2032)
- 10.4.1 China Kinase Panel Screening and Profiling Revenue by Application (2021-2026)
- 10.4.2 China Kinase Panel Screening and Profiling Revenue by Application (2027-2032)
- 10.5 China Kinase Panel Screening and Profiling Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Kinase Panel Screening and Profiling Revenue (2021-2032)
- 11.2 Asia Kinase Panel Screening and Profiling Revenue by Type (2021-2032)
- 11.2.1 Asia Kinase Panel Screening and Profiling Revenue by Type (2021-2026)
- 11.2.2 Asia Kinase Panel Screening and Profiling Revenue by Type (2027-2032)
- 11.3 Asia Kinase Panel Screening and Profiling Revenue Share by Type (2021-2032)
- 11.4 Asia Kinase Panel Screening and Profiling Revenue by Application (2021-2032)
- 11.4.1 Asia Kinase Panel Screening and Profiling Revenue by Application (2021-2026)
- 11.4.2 Asia Kinase Panel Screening and Profiling Revenue by Application (2027-2032)
- 11.5 Asia Kinase Panel Screening and Profiling Revenue Share by Application (2021-2032)
- 11.6 Asia Kinase Panel Screening and Profiling Revenue by Country
- 11.6.1 Asia Kinase Panel Screening and Profiling Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Kinase Panel Screening and Profiling Revenue by Country (2021-2026)
- 11.6.3 Asia Kinase Panel Screening and Profiling Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Kinase Panel Screening and Profiling Revenue (2021-2032)
- 12.2 SAMEA Kinase Panel Screening and Profiling Revenue by Type (2021-2032)
- 12.2.1 SAMEA Kinase Panel Screening and Profiling Revenue by Type (2021-2026)
- 12.2.2 SAMEA Kinase Panel Screening and Profiling Revenue by Type (2027-2032)
- 12.3 SAMEA Kinase Panel Screening and Profiling Revenue Share by Type (2021-2032)
- 12.4 SAMEA Kinase Panel Screening and Profiling Revenue by Application (2021-2032)
- 12.4.1 SAMEA Kinase Panel Screening and Profiling Revenue by Application (2021-2026)
- 12.4.2 SAMEA Kinase Panel Screening and Profiling Revenue by Application (2027-2032)
- 12.5 SAMEA Kinase Panel Screening and Profiling Revenue Share by Application (2021-2032)
- 12.6 SAMEA Kinase Panel Screening and Profiling Revenue by Country
- 12.6.1 SAMEA Kinase Panel Screening and Profiling Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Kinase Panel Screening and Profiling Revenue by Country (2021-2026)
- 12.6.3 SAMEA Kinase Panel Screening and Profiling Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst